Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial - Lorenzen, S; Götze, TO; Thuss-Patience, P (J Clin Oncol, 2023)
et al.